Ohio based innovation aims to combat future medical surge (medsurge) at home and abroad
Watch MustER's life saving support multiplier here.
MINIMIZE ECONOMIC LOSS.
STRENGTHEN NATIONAL SECURITY.
LESSEN HUMAN SUFFERING.
By increasing medical surge capacity, the MustER medical response system (MRS) will act as a force multiplier for war fighters as well as a support multiplier for the National Disaster Management System (NDMS) and the Global Security Health Agenda (GHSA).
The self-contained, modular 21st Century modern medical treatment facility, born in the era of COVID-19, improves upon the Combat Surgical Hospital (CSH) legacy program and lessons learned from the public health emergency preparedness and response to COVID-19, past disasters, and mass casualty incidents.
MustER – Military Response System (MRS)
The U.S. Combatant Commands require within the Force Protection & Medical category the need to provide “far-forward, remote/austere tactical combat casualty care/prolonged field care,” “to extend the golden hour,” and to provide “rapid response to pandemic influenza/infectious disease occurrences. MustER meets this need with a rapidly deployable, self-contained expeditionary medical treatment center designed to incorporate health care delivery modernization into the U.S. Armed Forces Future Power.
MUSTER - Civilian Alternate Care Site (ACS)
Equally important MUSTER serves as a support multiplier as part of the Military-Civilian National Disaster Medical System (NDMS) to care for our civilian and national combat casualties during a national emergency at home and abroad, as well as in support of the Global Health Security Agenda (GHSA).
“Few, if any, hospitals in America today could handle 100 patients suddenly demanding care. There is no metropolitan area, no geographically contiguous area, that could handle 1,000 people suddenly needing advanced medical care in this country right now.”
Source: U.S. Congress. Senate. Committee on Government Affairs.FEMA’s Role in Managing Bioterrorist Attacks and the Impact of Public Health Concerns on Bioterrorism Preparedness. 107th Cong., 1st sess., July 23, 2001.Testimony of Tara J. O’Toole, M.D., M.P.H., Johns Hopkins Center for Civilian Biodefense Studies.
For more information contact MustER CEO/Founder member Al Burzynski, APR, via Email
No DOD direct or implied endorsement.
Our medical countermeasure innovation will save lives on the battlefield in close-quarters armed conflict with near-peer adversaries, as well as to provide medical care to civilians at home and abroad who may be affected by a catastrophe such as COVID-19, mass casualty incidents, and healthcare disparities.
Our greatest strength is our teaming partners and support multipliers, such as GDI Partners, The Ohio State University Center for Design and Manufacturing Excellence (CDME), and the Janz Corporation, which augments our capability to support warfighters and emergency preparedness and response professionals.
MUSTER and its team of experts have spent countless hours conducting research, analysis, and consulting subject matter experts to develop the next generation of modern healthcare delivery systems. We considered military needs such as the CENTCOM Theater Trauma System Assessment Report and the Joint Commission Surge Hospital, mobile medical study as part of our efforts.
Albert Einstein said, “in the midst of every crisis, lies great opportunity.”
MUSTER is a team of experts from across the United States and the United Kingdom who responded to the call to duty and put their expertise to work developing a military-civilian medical surge concept to support America's warriors and join the fight against the COVID-19 pandemic.